Soligenix
SNGX
$0.36
Share price
-0.96%
Change (1 day)
-49.79%
Change (1 year)
Categories
Soligenix (SNGX) - Cash on Hand
Cash on Hand as of March 2024 : $7.09 M
According to Soligenix's latest financial reports the company has $7.09 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Soligenix - Cash on Hand chart (from 2001 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $13.35 M | -48.7% |
| 2021-12-31 | $26.04 M | 39.45% |
| 2020-12-31 | $18.67 M | 244.54% |
| 2019-12-31 | $5.42 M | -39.66% |
| 2018-12-31 | $8.98 M | 15.04% |
| 2017-12-31 | $7.8 M | -10.98% |
| 2016-12-31 | $8.77 M | 78.25% |
| 2015-12-31 | $4.92 M | -10.92% |
| 2014-12-31 | $5.52 M | -5.65% |
| 2013-12-31 | $5.85 M | 74.48% |
| 2012-12-31 | $3.35 M | -44.03% |
| 2011-12-31 | $5.99 M | -19.53% |
| 2010-12-31 | $7.45 M | -3.12% |
| 2009-12-31 | $7.69 M | 421.33% |
| 2008-12-31 | $1.47 M | -33.54% |
| 2007-12-31 | $2.22 M | 1755.74% |
| 2006-12-31 | $0.11 M | -85.44% |
| 2005-12-31 | $0.82 M | -64.77% |
| 2004-12-31 | $2.33 M | -43.36% |
| 2003-12-31 | $4.11 M | -0.71% |
| 2002-12-31 | $4.14 M | -58.29% |
| 2001-12-31 | $9.94 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $26.21 B | 369,607.61% | 🇺🇸 USA |
 Pfizer PFE | $11.92 B | 168,114.28% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 139,899.58% | 🇫🇷 France |
 Onconova Therapeutics ONTX | $16.39 M | 131.12% | 🇺🇸 USA |
 Athersys ATHX | $1.02 M | -85.62% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $2.99 B | 42,076.96% | 🇮🇱 Israel |
 Cleveland BioLabs
CBLI | N/A | N/A | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $78.5 M | 1,006.95% | 🇺🇸 USA |